171 related articles for article (PubMed ID: 11175334)
1. DNA damage-induced phosphorylation of p53 at serine 20 correlates with p21 and Mdm-2 induction in vivo.
Jabbur JR; Huang P; Zhang W
Oncogene; 2000 Dec; 19(54):6203-8. PubMed ID: 11175334
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the antiproliferative function of p53 by phosphorylation at serine 20: an inference from site-directed mutagenesis studies.
Jabbur JR; Huang P; Zhang W
Int J Mol Med; 2001 Feb; 7(2):163-8. PubMed ID: 11172619
[TBL] [Abstract][Full Text] [Related]
3. Mdm-2 binding and TAF(II)31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 and Asp21.
Jabbur JR; Tabor AD; Cheng X; Wang H; Uesugi M; Lozano G; Zhang W
Oncogene; 2002 Oct; 21(46):7100-13. PubMed ID: 12370832
[TBL] [Abstract][Full Text] [Related]
4. Dephosphorylation of p53 at Ser20 after cellular exposure to low levels of non-ionizing radiation.
Craig AL; Blaydes JP; Burch LR; Thompson AM; Hupp TR
Oncogene; 1999 Nov; 18(46):6305-12. PubMed ID: 10597229
[TBL] [Abstract][Full Text] [Related]
5. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
[TBL] [Abstract][Full Text] [Related]
6. DNA damage induces phosphorylation of the amino terminus of p53.
Siliciano JD; Canman CE; Taya Y; Sakaguchi K; Appella E; Kastan MB
Genes Dev; 1997 Dec; 11(24):3471-81. PubMed ID: 9407038
[TBL] [Abstract][Full Text] [Related]
7. Differences in mutant p53 protein stability and functional activity in teniposide-sensitive and -resistant human leukemic CEM cells.
Morgan SE; Kim R; Wang PC; Bhat UG; Kusumoto H; Lu T; Beck WT
Oncogene; 2000 Oct; 19(43):5010-9. PubMed ID: 11042688
[TBL] [Abstract][Full Text] [Related]
8. p53 Antiproliferative function is enhanced by aspartate substitution at threonine 18 and serine 20.
Jabbur JR; Zhang W
Cancer Biol Ther; 2002; 1(3):277-83. PubMed ID: 12432277
[TBL] [Abstract][Full Text] [Related]
9. Limited role of N-terminal phosphoserine residues in the activation of transcription by p53.
Jackson MW; Agarwal MK; Agarwal ML; Agarwal A; Stanhope-Baker P; Williams BR; Stark GR
Oncogene; 2004 May; 23(25):4477-87. PubMed ID: 15064747
[TBL] [Abstract][Full Text] [Related]
10. UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts.
Latonen L; Taya Y; Laiho M
Oncogene; 2001 Oct; 20(46):6784-93. PubMed ID: 11709713
[TBL] [Abstract][Full Text] [Related]
11. An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines.
Bae I; Smith ML; Sheikh MS; Zhan Q; Scudiero DA; Friend SH; O'Connor PM; Fornace AJ
Cancer Res; 1996 Feb; 56(4):840-7. PubMed ID: 8631022
[TBL] [Abstract][Full Text] [Related]
12. Cisplatinum and taxol induce different patterns of p53 phosphorylation.
Damia G; Filiberti L; Vikhanskaya F; Carrassa L; Taya Y; D'incalci M; Broggini M
Neoplasia; 2001; 3(1):10-6. PubMed ID: 11326311
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of serines 15 and 37 is necessary for efficient accumulation of p53 following irradiation with UV.
Bean LJ; Stark GR
Oncogene; 2001 Mar; 20(9):1076-84. PubMed ID: 11314044
[TBL] [Abstract][Full Text] [Related]
14. Human melanoma cell line UV responses show independency of p53 function.
Haapajärvi T; Pitkänen K; Laiho M
Cell Growth Differ; 1999 Mar; 10(3):163-71. PubMed ID: 10099830
[TBL] [Abstract][Full Text] [Related]
15. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2.
Unger T; Juven-Gershon T; Moallem E; Berger M; Vogt Sionov R; Lozano G; Oren M; Haupt Y
EMBO J; 1999 Apr; 18(7):1805-14. PubMed ID: 10202144
[TBL] [Abstract][Full Text] [Related]
16. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA
J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
[TBL] [Abstract][Full Text] [Related]
17. [Gastric cancer and tumor growth regulation. Study of cell proliferation markers and protein complex p53/p21WAF1/CIP1/mdm-2].
Villaseca M; Araya JC; Roa I; Roa JC
Rev Med Chil; 2000 Feb; 128(2):127-36. PubMed ID: 10962880
[TBL] [Abstract][Full Text] [Related]
18. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
[TBL] [Abstract][Full Text] [Related]
19. Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers.
Craig AL; Burch L; Vojtesek B; Mikutowska J; Thompson A; Hupp TR
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):133-41. PubMed ID: 10432310
[TBL] [Abstract][Full Text] [Related]
20. Pin-ning down p53 function.
Pulverer B
Nat Cell Biol; 2002 Nov; 4(11):E251. PubMed ID: 12415280
[No Abstract] [Full Text] [Related]
[Next] [New Search]
